Item 16. FORM 10-K SUMMARY

4K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

None.

-119-


PART IV			Signatures
RESMED INC. AND SUBSIDIARIES

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

DATED August 13, 2026

ResMed Inc.


/s/ MICHAEL J. FARRELL
Michael J. Farrell
Chief Executive Officer
(Principal Executive Officer)

-120-

Table of Contents


PART IV			Signatures
RESMED INC. AND SUBSIDIARIES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.


SIGNATURE	TITLE	DATE

/S/ MICHAEL J. FARRELL	Chief Executive Officer and Chairman	August 13, 2026
Michael J. Farrell	(Principal Executive Officer)

/S/ AARON BLOOMER	Chief Financial Officer	August 13, 2026
Aaron Bloomer	(Principal Financial Officer and Principal Accounting Officer)

/S/ PETER C. FARRELL	Director and Chair Emeritus	August 13, 2026
Peter C. Farrell

/S/ CAROL J. BURT	Director	August 13, 2026
Carol J. Burt

/S/ CHRISTOPHER DELOREFICE	Director	August 13, 2026
Christopher DelOrefice

/S/ JAN DE WITTE	Director	August 13, 2026
Jan De Witte

/S/ KAREN DREXLER	Director	August 13, 2026
Karen Drexler

/S/ HARJIT GILL	Director	August 13, 2026
Harjit Gill

/S/ JOHN HERNANDEZ	Director	August 13, 2026
John Hernandez

/S/ NICOLE MOWAD-NASSAR	Director	August 13, 2026
Nicole Mowad-Nassar

/S/ DESNEY TAN	Director	August 13, 2026
Desney Tan

/S/ RON TAYLOR	Director	August 13, 2026
Ron Taylor

-121-

Previous: Item 15. EXHIBITS AND CONSOLIDATED FINANCIAL STATEMENT SCHEDULES